$244 Million is the total value of DAFNA Capital Management LLC's 75 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 10.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LOXO | Buy | LOXO ONCOLOGY INC | $28,986,000 | +5.3% | 169,675 | +6.9% | 11.90% | -7.6% |
| STXS | STEREOTAXIS INC | $16,553,000 | +57.1% | 13,680,554 | 0.0% | 6.80% | +37.8% | |
| SAGE | Buy | SAGE THERAPEUTICS INC | $14,027,000 | -6.7% | 99,306 | +3.4% | 5.76% | -18.1% |
| ATRC | Sell | ATRICURE INC | $10,289,000 | +20.6% | 293,729 | -6.9% | 4.22% | +5.8% |
| NXTM | NXSTAGE MEDICAL INC | $8,538,000 | -0.0% | 306,119 | 0.0% | 3.51% | -12.3% | |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $8,172,000 | -8.2% | 132,770 | +0.8% | 3.36% | -19.5% |
| BPMC | BLUEPRINT MEDICINES CORP | $7,235,000 | +23.0% | 92,691 | 0.0% | 2.97% | +7.8% | |
| ZGNX | Buy | ZOGENIX INC | $6,858,000 | +58.7% | 138,264 | +41.4% | 2.82% | +39.2% |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $6,594,000 | +5.4% | 396,013 | 0.0% | 2.71% | -7.6% | |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $5,525,000 | -9.4% | 625,738 | +2.5% | 2.27% | -20.5% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $5,473,000 | +11.6% | 77,242 | +4.7% | 2.25% | -2.2% |
| DXCM | Sell | DEXCOM INC | $5,292,000 | +1.3% | 37,000 | -32.7% | 2.17% | -11.2% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $5,042,000 | +12.8% | 41,008 | -9.9% | 2.07% | -1.1% |
| PRQR | Buy | PROQR THERAPEUTICS N V | $5,038,000 | +302.7% | 260,336 | +51.9% | 2.07% | +253.1% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $4,975,000 | +43.6% | 652,086 | +7.8% | 2.04% | +26.0% |
| ARGX | Buy | ARGENX SEsponsored adr | $4,877,000 | +126.8% | 64,300 | +147.8% | 2.00% | +98.9% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $4,630,000 | +173.5% | 808,000 | +139.1% | 1.90% | +139.7% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $4,535,000 | +9.2% | 98,547 | +3.5% | 1.86% | -4.2% |
| GLPG | Sell | GALAPAGOS NVspon adr | $4,453,000 | +19.0% | 39,609 | -2.5% | 1.83% | +4.3% |
| KURA | Buy | KURA ONCOLOGY INC | $4,209,000 | -3.4% | 240,500 | +0.4% | 1.73% | -15.3% |
| LMNX | Sell | LUMINEX CORP | $4,195,000 | -16.4% | 138,391 | -18.5% | 1.72% | -26.6% |
| IMMU | Sell | IMMUNOMEDICS INC | $3,708,000 | -14.4% | 178,000 | -2.7% | 1.52% | -24.9% |
| CBAY | CYMABAY THERAPEUTICS INC | $3,263,000 | -17.4% | 294,511 | 0.0% | 1.34% | -27.6% | |
| IBB | ISHARES TR NASDAQ BIOTECHetf | $3,183,000 | +11.1% | 26,100 | 0.0% | 1.31% | -2.6% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $3,137,000 | +15.8% | 237,683 | -19.3% | 1.29% | +1.6% |
| ACHN | Sell | ACHILLION PHARMACEUTICALS | $3,119,000 | +16.3% | 847,636 | -10.6% | 1.28% | +2.0% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,080,000 | -17.3% | 4,000,000 | 0.0% | 1.26% | -27.5% | ||
| MNLO | MENLO THERAPEUTICS INC | $3,073,000 | +21.3% | 312,000 | 0.0% | 1.26% | +6.4% | |
| Sell | INTEC PHARMA LTD JERUSALEM | $3,034,000 | +21.3% | 537,000 | -5.6% | 1.25% | +6.4% | |
| BEAT | Sell | BIOTELEMETRY INC | $3,016,000 | +23.0% | 46,800 | -14.1% | 1.24% | +7.7% |
| BLUE | Buy | BLUEBIRD BIO INC | $2,993,000 | +376.6% | 20,500 | +412.5% | 1.23% | +318.0% |
| CARA | Buy | CARA THERAPEUTICS INC | $2,702,000 | +124.6% | 112,811 | +79.6% | 1.11% | +97.2% |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $2,627,000 | +68.6% | 359,860 | -14.5% | 1.08% | +48.0% |
| ARQL | Buy | ARQULE INC | $2,534,000 | +143.0% | 447,664 | +137.3% | 1.04% | +113.3% |
| WVE | WAVE LIFE SCIENCES LTD | $2,395,000 | +30.7% | 47,900 | 0.0% | 0.98% | +14.6% | |
| VBIV | VBI VACCINES INC | $2,262,000 | -12.0% | 934,691 | 0.0% | 0.93% | -22.8% | |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $2,200,000 | +14.9% | 56,200 | -5.1% | 0.90% | +0.7% |
| ARDX | ARDELYX INC | $2,057,000 | +17.5% | 472,859 | 0.0% | 0.84% | +3.2% | |
| INSULET CORPnote 1.375% | $1,909,000 | +14.7% | 1,500,000 | 0.0% | 0.78% | +0.6% | ||
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $1,808,000 | +34.1% | 118,500 | +7.7% | 0.74% | +17.6% |
| MGNX | MACROGENICS INC | $1,679,000 | +3.8% | 78,305 | 0.0% | 0.69% | -9.0% | |
| ADXS | Buy | ADVAXIS INC | $1,567,000 | +55.0% | 1,666,666 | +139.1% | 0.64% | +35.9% |
| SCYX | Sell | SCYNEXIS INC | $1,528,000 | -27.0% | 1,272,927 | -0.2% | 0.63% | -36.0% |
| TBIO | Buy | TRANSLATE BIO INC | $1,517,000 | +499.6% | 151,739 | +658.7% | 0.62% | +428.0% |
| INCY | INCYTE CORP | $1,485,000 | +3.1% | 21,500 | 0.0% | 0.61% | -9.6% | |
| NTUS | NATUS MEDICAL INC | $1,351,000 | +3.3% | 37,900 | 0.0% | 0.56% | -9.3% | |
| NVAX | Sell | NOVAVAX INC | $1,316,000 | +30.9% | 700,000 | -6.7% | 0.54% | +14.6% |
| JNJ | JOHNSON AND JOHNSON | $1,299,000 | +13.8% | 9,400 | 0.0% | 0.53% | -0.2% | |
| IMDZ | IMMUNE DESIGN CORP | $1,133,000 | -24.2% | 328,500 | 0.0% | 0.46% | -33.6% | |
| BHVN | Buy | BIOHAVEN PHARMACEUTICALS HOLD | $1,127,000 | +21.3% | 30,000 | +27.7% | 0.46% | +6.4% |
| LPTX | Sell | LEAP THERPEUTICS INC | $1,096,000 | -19.7% | 140,643 | -7.3% | 0.45% | -29.6% |
| ZFGN | Sell | ZAFGEN INC | $1,003,000 | -40.0% | 85,842 | -47.5% | 0.41% | -47.3% |
| CDTX | CIDARA THERAPEUTICS INC | $936,000 | -15.4% | 212,766 | 0.0% | 0.38% | -25.9% | |
| OBSV | Sell | OBSEVA SA | $781,000 | -20.6% | 43,338 | -33.3% | 0.32% | -30.4% |
| SNSS | SUNESIS PHARMACEUTICALS INC | $747,000 | -5.7% | 373,702 | 0.0% | 0.31% | -17.3% | |
| SPRO | New | SPERO THERAPEUTICS INC | $736,000 | – | 70,000 | +100.0% | 0.30% | – |
| URGN | Buy | UROGEN PHARMA LTD | $708,000 | +42.2% | 15,000 | +50.0% | 0.29% | +24.9% |
| CYTK | Sell | CYTOKINETICS INC | $617,000 | +7.1% | 62,690 | -9.7% | 0.25% | -6.3% |
| RIGL | RIGEL PHARMACEUTICALS INC | $442,000 | +13.6% | 137,600 | 0.0% | 0.18% | 0.0% | |
| NTGN | NEON THERAPEUICS INC | $427,000 | -32.2% | 50,000 | 0.0% | 0.18% | -40.7% | |
| APTX | Sell | APTINYX INC | $420,000 | -30.5% | 14,500 | -42.0% | 0.17% | -39.2% |
| STRO | New | SUTRO BIOPHARMA INC | $412,000 | – | 27,494 | +100.0% | 0.17% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $396,000 | – | 10,673 | +100.0% | 0.16% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $392,000 | – | 17,725 | +100.0% | 0.16% | – |
| DEXCOM INCnote 0.750% 5/1 | $383,000 | +33.0% | 250,000 | 0.0% | 0.16% | +16.3% | ||
| MASI | Sell | MASIMO CORPORATION | $374,000 | -23.4% | 3,000 | -40.0% | 0.15% | -32.5% |
| RDUS | Buy | RADIUS HEALTH INC | $365,000 | +23.7% | 20,500 | +105.0% | 0.15% | +8.7% |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $338,000 | -68.7% | 26,907 | -79.4% | 0.14% | -72.5% |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $269,000 | +3.1% | 250,000 | 0.0% | 0.11% | -9.8% | ||
| SLGL | SOL GEL TECHNOLOGIES LTD | $263,000 | -2.6% | 35,000 | 0.0% | 0.11% | -14.3% | |
| BTX | Sell | BIOTIME INC | $235,000 | -37.2% | 100,000 | -44.9% | 0.10% | -44.6% |
| KDMN | Sell | KADMON HOLDINGS INC | $210,000 | -19.5% | 63,000 | -3.8% | 0.09% | -29.5% |
| BLCM | BELLICUM PHARMACEUTICALS INC | $185,000 | -16.3% | 30,000 | 0.0% | 0.08% | -26.2% | |
| NEOS | NEOS THERAPEUTICS INC | $133,000 | -22.7% | 27,500 | 0.0% | 0.06% | -32.1% | |
| DERM | Sell | DERMIRA INC | $55,000 | -74.1% | 5,000 | -78.3% | 0.02% | -76.8% |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -10,000 | -100.0% | -0.08% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -2,000 | -100.0% | -0.14% | – |
| GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -50,000 | -100.0% | -0.28% | – |
| Exit | PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $0 | – | -2,500,000 | -100.0% | -1.11% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.